Showing results (1-10 of 459) with videos related to
Sort By:
Pageof 46
Chinese Clinical Oncology|May 12, 2016
Appropriate margin for lumpectomy excision of invasive breast cancerAndrea V Barrio, Monica MorrowBreast Cancer Research and Treatment|July 28, 2025
Axillary dissection is avoidable in most cT1N0 triple-negative & HER2+ breast cancers treated with upfront surgeryAnita Mamtani, Varadan Sevilimedu, Andrea V Barrio, et al.Cancer|October 1, 2021
Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?Anita Mamtani, Varadan Sevilimedu, Tiana Le, et al.Annals of Surgical Oncology|July 28, 2022
Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?Giacomo Montagna, Minna K Lee, Varadan Sevilimedu, et al.Annals of Surgery|May 13, 2026
Diagnosing Lymphedema After Axillary Surgery: A Prospective Comparison of Bioimpedance, Tape Measurement, and Perometer in Patients Treated with Axillary Lymph Node DissectionAndrea V Barrio, Brian Diskin, Bayley Axelrod, et al.Annals of Surgical Oncology|July 24, 2022
Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals?Austin D Williams, Chau T Dang, Varadan Sevilimedu, et al.Annals of Surgical Oncology|June 10, 2020
How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?Oriana Petruolo, Varadan Sevilimedu, Giacomo Montagna, et al.Annals of Surgical Oncology|January 29, 2017
Is Routine Axillary Imaging Necessary in Clinically Node-Negative Patients Undergoing Neoadjuvant Chemotherapy?Andrea V Barrio, Anita Mamtani, Anne Eaton, et al.Annals of Surgical Oncology|June 4, 2020
Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant ChemotherapyGiacomo Montagna, Anita Mamtani, Andrea Knezevic, et al.Annals of Surgical Oncology|August 2, 2017
The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor SubtypeMelissa Pilewskie, Emily C Zabor, Anita Mamtani, et al.Pageof 46